Ventricular Repolarization in Patients With Premature Ovarian Insufficiency (QTIOP) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ventricular Repolarization in Patients With Premature Ovarian Insufficiency (QTIOP) — Stella

Home/Premature Ovarian Insufficiency/

View on ClinicalTrials.gov

Recruiting

Back to Premature Ovarian Insufficiency trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

France

Hopital Haut Leveque, Bordeaux

BACHELOT, Paris

Pitié Salpêtrière, Paris

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~120 participants

Started

April 2021

Primary completion

April 2027

Age range

18 Years – 40 Years

Sex

Female only

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.